Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

Lobbying Update: $440,000 of ACADIA PHARMACEUTICALS lobbying was just disclosed

None

$440,000 of ACADIA PHARMACEUTICALS lobbying was just disclosed, from Q1 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Implementation of the Inflation Reduction Act of 2022; Orphan Cures Act (HR 946); National Plan to End Parkinsons Act (Public Law 118-66, 118th Congress); Give Kids A Chance (HR1262); Cameron's Law (HR1414). Implementation of the Inflation Reduction Act of 2022; Issues related to protecting patient access to medicines in Medicare; Issues related to access to medicines for Parkinson's disease patients; Issues related to Antipsychotic use in Medicare; Orphan Cures Act (HR 946); National Plan to End Parkinsons Act (Public Law 118-66, 118th Congress); EPIC Act (HR 1492). Cameron's Law (HR 14114)"

You can find more data on corporate lobbying on Quiver Quantitative.

ACAD Insider Trading Activity

ACAD insiders have traded $ACAD stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.

Here’s a breakdown of recent trading of $ACAD stock by insiders over the last 6 months:

  • MARK C. SCHNEYER (EVP, CHIEF FINANCIAL OFFICER) has made 0 purchases and 4 sales selling 16,911 shares for an estimated $282,080.
  • BRENDAN TEEHAN (EVP, COO, HEAD OF COMMERCIAL) sold 10,329 shares for an estimated $173,630
  • JAMES KIHARA (PRINCIPAL ACCOUNTING OFFICER) has made 0 purchases and 4 sales selling 6,671 shares for an estimated $111,852.
  • ELIZABETH A. GAROFALO sold 4,919 shares for an estimated $89,673

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

ACAD Hedge Fund Activity

We have seen 167 institutional investors add shares of ACAD stock to their portfolio, and 101 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • MORGAN STANLEY added 5,621,195 shares (+335.4%) to their portfolio in Q4 2024, for an estimated $103,148,928
  • RTW INVESTMENTS, LP removed 5,002,005 shares (-36.5%) from their portfolio in Q4 2024, for an estimated $91,786,791
  • ASSENAGON ASSET MANAGEMENT S.A. added 3,663,145 shares (+inf%) to their portfolio in Q1 2025, for an estimated $60,844,838
  • SG AMERICAS SECURITIES, LLC removed 2,465,581 shares (-99.3%) from their portfolio in Q1 2025, for an estimated $40,953,300
  • POINT72 ASSET MANAGEMENT, L.P. added 2,230,815 shares (+inf%) to their portfolio in Q4 2024, for an estimated $40,935,455
  • CITIGROUP INC added 1,547,641 shares (+1288.3%) to their portfolio in Q4 2024, for an estimated $28,399,212
  • STATE STREET CORP removed 1,452,489 shares (-24.3%) from their portfolio in Q4 2024, for an estimated $26,653,173

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles